🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/11/2018 | 73,65 | 74,89 | 73,58 | 74,34 | +0,88% | 1,77% | 11.429.174 |
| 28/11/2018 | 73,28 | 73,82 | 72,78 | 73,69 | +1,17% | 1,42% | 12.625.675 |
| 27/11/2018 | 71,63 | 73,02 | 71,63 | 72,84 | +1,19% | 1,93% | 15.325.533 |
| 26/11/2018 | 71,56 | 72,28 | 71,36 | 71,98 | +1,03% | 1,28% | 11.407.061 |
| 23/11/2018 | 70,73 | 71,85 | 70,62 | 71,25 | -0,16% | 1,74% | 3.690.846 |
| 21/11/2018 | 71,49 | 71,63 | 70,78 | 71,36 | +0,01% | 1,19% | 9.489.116 |
| 20/11/2018 | 72,53 | 72,86 | 71,23 | 71,36 | -2,06% | 2,25% | 14.240.014 |
| 19/11/2018 | 72,73 | 73,10 | 72,13 | 72,85 | +0,38% | 1,34% | 17.210.675 |
| 16/11/2018 | 71,32 | 72,76 | 71,14 | 72,58 | +1,63% | 2,27% | 14.384.010 |
| 15/11/2018 | 70,13 | 71,44 | 69,78 | 71,41 | +1,01% | 2,37% | 12.549.171 |
| 14/11/2018 | 71,52 | 71,53 | 70,31 | 70,70 | -0,70% | 1,71% | 9.936.193 |
| 13/11/2018 | 71,77 | 71,82 | 70,62 | 71,19 | -0,11% | 1,68% | 16.587.430 |
| 12/11/2018 | 71,69 | 71,82 | 70,64 | 71,27 | -0,23% | 1,65% | 14.679.022 |
| 09/11/2018 | 72,39 | 72,51 | 71,37 | 71,43 | -0,82% | 1,57% | 15.359.802 |
| 08/11/2018 | 71,46 | 72,22 | 71,20 | 72,02 | +0,53% | 1,43% | 13.634.690 |
| 07/11/2018 | 70,71 | 71,88 | 70,46 | 71,64 | +2,41% | 2,01% | 19.566.684 |
| 06/11/2018 | 69,60 | 70,42 | 69,42 | 69,95 | +0,26% | 1,44% | 10.737.913 |
| 05/11/2018 | 68,66 | 70,20 | 66,91 | 69,77 | +1,18% | 4,79% | 12.922.364 |
| 02/11/2018 | 70,20 | 70,32 | 68,34 | 68,96 | -1,16% | 2,83% | 13.517.838 |
| 01/11/2018 | 70,42 | 70,65 | 69,34 | 69,77 | -0,67% | 1,86% | 14.507.988 |
| 31/10/2018 | 70,05 | 71,08 | 69,44 | 70,24 | +1,02% | 2,34% | 16.624.529 |
| 30/10/2018 | 68,41 | 69,62 | 68,23 | 69,53 | +1,99% | 2,04% | 19.845.976 |
| 29/10/2018 | 68,10 | 69,69 | 67,32 | 68,18 | +1,49% | 3,47% | 19.743.901 |
| 26/10/2018 | 66,57 | 67,54 | 65,73 | 67,18 | +0,63% | 2,72% | 17.764.229 |
| 25/10/2018 | 63,87 | 67,34 | 63,07 | 66,76 | -0,82% | 6,68% | 21.553.692 |
| 24/10/2018 | 68,53 | 69,31 | 67,01 | 67,31 | -2,16% | 3,36% | 15.348.170 |
| 23/10/2018 | 68,86 | 69,10 | 67,96 | 68,80 | -0,65% | 1,66% | 12.116.871 |
| 22/10/2018 | 69,63 | 70,12 | 68,56 | 69,25 | +0,30% | 2,25% | 12.486.186 |
| 19/10/2018 | 68,99 | 69,33 | 68,65 | 69,04 | +0,19% | 1,00% | 15.210.043 |
| 18/10/2018 | 68,85 | 69,08 | 68,15 | 68,90 | +0,54% | 1,36% | 12.812.848 |